Pacer Advisors, Inc. Spring Works Therapeutics, Inc. Transaction History

Pacer Advisors, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$36.06 - $47.62 $1,911 - $2,523	53 Added 6.35%	887 $33,000
Q1 2024 May 10, 2024	BUY	$36.5 - $52.5 $30,441 - $43,785	834 New	834 $41,000
Q2 2021 Jul 21, 2021	SELL	$67.45 - $85.63 $66,640 - $84,602	-988 Closed	0 $0
Q1 2021 Apr 05, 2021	SELL	$65.1 - $93.59 $20,962 - $30,135	-322 Reduced 24.58%	988 $73,000
Q4 2020 Jan 20, 2021	BUY	$48.36 - $77.92 $63,351 - $102,075	1,310 New	1,310 $95,000

239

70.8M

151K

255K

Ticker SWTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,401,100
Market Cap $3.58B
Description
SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...

Get notified when there are updates to the investment portfolio of Pacer Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Pacer Advisors, Inc. with notifications on news.